+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Faron Pharmaceuticals  - logo

Faron pharmaceuticals was founded in 2003 in Turku, Finland. It is a clinical stage drug discovery and development company. The company focuses on acute organ traumas, vascular damage, and cancer immunotherapy. Faron pharma is most well known for Traumakine, to prevent vascular leakage and organ failures, is currently the only treatment for Acute Respiratory Distress Syndrome (ARDS) undergoing Phase III clinical trials. It also develops Clevegen, a preclinical immunotherapy candidate, designed to prevent tumor growth and metastasis that targets the tumor immune suppressor molecule.

Tuberculosis - Pipeline Insight, 2022 - Product Thumbnail Image

Tuberculosis - Pipeline Insight, 2022

  • Clinical Trials
  • March 2022
  • 60 Pages
  • Global
From
From
Pertussis (Whooping Cough) - Pipeline Review, H1 2020 - Product Thumbnail Image

Pertussis (Whooping Cough) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 127 Pages
  • Global
From
From
Tuberculosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Tuberculosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 419 Pages
  • Global
From
From
From
Pertussis - Pipeline Insight, 2022 - Product Thumbnail Image

Pertussis - Pipeline Insight, 2022

  • Drug Pipelines
  • November 2022
  • 70 Pages
  • Global
From
From
From
From
From
From
Loading Indicator